SPY393.89-3.03 -0.76%
DIA319.39+0.55 0.17%
IXIC11,264.45-270.83 -2.35%

Medicenna up 7.3% in US Pre-Market as Details Promising New Clinical Data From Phase 1/2 ABILITY Study

MT Newswires · 05/02/2022 04:31

Please log in to view news